VRTX•benzinga•
Vertex Has A Lot Riding On Alyftrek, Journavx — And Investors Are Watching Closely
Summary
Vertex Pharmaceuticals is expected to report first quarter earnings on May 5, with investor focus on its two big launches and potential upside surprises.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 21, 2025 by benzinga